Get the Stockscreener App
0.5169
12.94%
-0.0804
Aditxt Inc stock is traded at $0.5169, with a volume of 751.01K.
It is down -12.94% in the last 24 hours and down -86.04% over the past month.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.
See More
Previous Close:
$0.5973
Open:
$0.5231
24h Volume:
751.01K
Relative Volume:
1.53
Market Cap:
$269.08K
Revenue:
$3,200
Net Income/Loss:
$-42.79M
P/E Ratio:
-0.000069
EPS:
-7534.7458
Net Cash Flow:
$-25.70M
1W Performance:
-46.88%
1M Performance:
-86.04%
6M Performance:
-99.91%
1Y Performance:
-99.98%
1-Day Range:
$0.5001
$0.5349
1-Week Range:
$0.5001
$1.1399
52-Week Range:
$0.5001
$3,426.16
Aditxt Inc Stock (ADTX) Company Profile
Name
Aditxt Inc
Sector
Industry
Phone
909-488-0844
Address
737 N. FIFTH STREET, SUITE 200, RICHMOND
Compare ADTX vs VRTX, REGN, ARGX, ALNY, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADTX
Aditxt Inc
|
0.5196 | 309.32K | 3,200 | -42.79M | -25.70M | -7,534.75 |
VRTX
Vertex Pharmaceuticals Inc
|
430.23 | 110.47B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.25 | 80.67B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
759.10 | 46.53B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
317.99 | 43.81B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.36 | 35.36B | 606.42M | -1.28B | -997.58M | -6.403 |
Aditxt Inc Stock (ADTX) Latest News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - benzinga.com
12 Health Care Stocks Moving In Monday's After-Market SessionAditxt (NASDAQ:ADTX), Advanced Biomed (NA - benzinga.com
12 Health Care Stocks Moving In Monday's Intraday SessionABVC BioPharma (NASDAQ:ABVC), Aditxt (NASDAQ - benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session - benzinga.com
Setup Watch: Can Aditxt Inc grow without external funding2026 Setups & Long-Term Safe Investment Plans - baoquankhu1.vn
ADTX | Aditxt, Inc. Common Stock Executive Compensation - quiverquant.com
Aditxt (NASDAQ: ADTX) seeks reverse stock split and say-on-pay nod - Stock Titan
Aditxt regains compliance with Nasdaq listing standards following equity increase - Investing.com
Aditxt regains Nasdaq compliance after equity rises to $3.95M - TradingView
Aditxt (NASDAQ: ADTX) back in line with Nasdaq equity listing rules - Stock Titan
ADTX Stock Price, Quote & Chart | ADITXT INC (NASDAQ:ADTX) - ChartMill
Aditxt 10-K: Revenue $0.003M, Net loss $42.79M, EPS $(1,153.83) - TradingView
Heavy losses and Nasdaq risk at Aditxt (NASDAQ: ADTX) in 2025 10-K - Stock Titan
Aditxt, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Aditxt Expands At-The-Market Equity Offering Capacity - The Globe and Mail
Returns Recap: How does Aditxt Inc perform in inflationary periods2026 Institutional & Real-Time Volume Triggers - baoquankhu1.vn
Aditxt, Inc. Files Form 8-K for At-The-Market Offering—Key Details and Legal Opinion Included - Minichart
Aditxt increases at-the-market offering size by $36.8 million on Nasdaq - Investing.com
Aditxt increases ATM offering capacity by $36.8M, raising potential to $53.4M - TradingView
[8-K] Aditxt, Inc. Reports Material Event - Stock Titan
Trading Action: Does Aditxt Inc stock benefit from AI growth2026 Outlook & AI Forecasted Stock Moves - baoquankhu1.vn
ADTX (NASDAQ: ADTX) raises at‑the‑market capacity to $53.4M - stocktitan.net
Aditxt acquires Ignite Proteomics to expand precision oncology capabilities - MSN
Aditxt (ADTX) to vote on directors, auditor, say-on-pay, reverse split - Stock Titan
Travel Stocks: Should value investors consider Aditxt IncEarnings Growth Report & Proven Capital Preservation Methods - baoquankhu1.vn
Aug Technicals: Can Aditxt Inc grow without dilutionCPI Data & Daily Entry Point Trade Alerts - baoquankhu1.vn
Aditxt names Jeff Busch CEO of Ignite Proteomics subsidiary By Investing.com - Investing.com Canada
IMAC Surrenders Ignite Assets; Proposed $35 Million Sale to Aditxt and $36 Million Financing - TradingView
IMAC Holdings (BACK) gives up Ignite assets to satisfy defaulted notes and links $36M ADTX preferred deal - Stock Titan
Aditxt names Jeff Busch CEO of Ignite Proteomics subsidiary - Investing.com
Aditxt Subsidiary Ignite Proteomics Appoints Public Company Veteran Jeff Busch as Chief Executive Officer - marketscreener.com
Targets Report: What are the risks of holding Aditxt Inc2026 Snapshot & Safe Swing Trade Setup Alerts - baoquankhu1.vn
ADTX Technical Analysis | Trend, Signals & Chart Patterns | ADITXT INC (NASDAQ:ADTX) - ChartMill
12 Health Care Stocks Moving In Friday's Intraday Session - Sahm
Aditxt Finalizes Ignite Proteomics Acquisition, Strengthening Oncology Focus - The Globe and Mail
Aditxt acquires precision oncology firm Ignite Proteomics By Investing.com - Investing.com South Africa
Aditxt (ADTX) Acquires Ignite Proteomics, Shares Drop 37% - GuruFocus
Aditxt acquires Ignite Proteomics in $36M preferred stock deal; shares down - MSN
Aditxt Backs Acquisition of Ignite Proteomics - themiddlemarket.com
Aditxt acquires precision oncology firm Ignite Proteomics - Investing.com Nigeria
Aditxt (ADTX) Acquires Ignite Proteomics in $36M Stock Deal - GuruFocus
Aditxt Buys Ignite Proteomics for $36M in Preferred Stock and Secures $2.88M Note Financing - TradingView
Aditxt (NASDAQ: ADTX) buys Ignite Proteomics with $36M preferred stock, adds notes - Stock Titan
Aditxt cancer move: Ignite Proteomics to guide therapy for 600,000 - Stock Titan
Aditxt, Inc. acquired Ignite Proteomics LLC from IMAC Holdings, Inc. and others for approximately $36 million. - marketscreener.com
Aditxt to implement 1-for-8 reverse stock split on March 9 - Investing.com Nigeria
ADTX SEC FilingsAditxt Inc 10-K, 10-Q, 8-K Forms - Stock Titan
ETF Watch: Does Aditxt Inc stock benefit from AI growth2025 Analyst Calls & Weekly Top Performers Watchlists - baoquankhu1.vn
Aditxt Implements Reverse Stock Split to Maintain Nasdaq Listing - The Globe and Mail
Guidance Update: Is Aditxt Inc forming a bullish divergenceWall Street Watch & Weekly Watchlist of Top Performers - baoquankhu1.vn
Aditxt (ADTX) Implements 1-for-8 Reverse Stock Split - GuruFocus
Aditxt Inc Stock (ADTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Aditxt Inc Stock (ADTX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Pankovcin Corinne | Chief M&A Officer |
Nov 25 '25 |
Sale |
3.20 |
1 |
3 |
0 |
0.92%
1.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):